The GU Cancer Forum Lugano 2027 brings together oncologists, urologists, medical professionals and specialists in genitourinary oncology to discuss the latest advances in the diagnosis and treatment of urogenital cancers.

Taking place on April 2027 in Lugano, Switzerland, the forum provides a focused platform for reviewing the most important new findings and clinical developments in genitourinary cancer, with particular attention to prostate cancer and urothelial carcinoma. The event is organised by the Swiss Cancer Institute and is conducted in Italian.

The GU Cancer Forum Lugano 2027 reviews key highlights from major international oncology congresses, including ASCO GU, EAU, AUA, ASCO, ESMO, ESTRO and ASTRO. The programme is designed to provide healthcare professionals with a concise and up-to-date overview of significant developments relevant to clinical practice.

The forum offers an opportunity for specialists to exchange knowledge, discuss emerging evidence and explore developments in the management of urogenital malignancies. With contributions from experienced experts in oncology and urology, the event supports continuing medical education and professional exchange within the GU cancer community.

Whether you are an oncologist, urologist, medical researcher or healthcare professional, GU Cancer Forum Lugano 2027 offers an opportunity to stay informed about the latest developments in genitourinary oncology and connect with specialists working in the field.